Graphene Nano-Structure Anti-Inflammatory Composition
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for inflammatory bowel disease lack effective therapeutic agents, leading to high side effects from combination therapies, and there is a need for more diverse anti-inflammatory ingredients beyond natural substances.
Innovation Solution
A pharmaceutical composition comprising a graphene nano-structure, specifically nano-sized graphene oxide or graphene quantum dots, which inhibits inflammatory factor expression and cytokine secretion, inducing differentiation of macrophages into anti-inflammatory subtypes to treat inflammatory bowel disease.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If general anti-inflammatory drugs, adrenal cortical hormones, immunosuppressive agents, and antibiotics are used in combination for treating inflammatory bowel disease, then the possibility of side effects increases
Solution Approach 1:
The patent extracts and isolates a specific natural substance (graphene nano-structure) from complex combination therapies. By focusing on a single active ingredient with demonstrated anti-inflammatory activity, the invention eliminates the need for multiple drugs, thereby reducing side effects while maintaining therapeutic effectiveness for inflammatory bowel disease
Solution Approach 2:
The invention employs a novel natural substance (graphene nano-structure) that has not been previously explored in medical treatments. This single-use, targeted therapeutic agent replaces long-term combination therapy regimens, providing effective treatment with reduced cumulative side effects
2Adaptability or versatility
If natural substance-derived ingredients are used for inhibiting excessive production of NO and skin inflammation, then the research is still in its infancy and more diverse ingredients are required
Solution Approach 1:
The patent transforms the physical and chemical parameters of graphene into a nano-structure form with specific size ranges (1-100 nm diameter, 0.3-5 nm thickness). This parameter change enables the graphene to exhibit enhanced anti-inflammatory activity and macrophage differentiation effects, making it an effective therapeutic agent for inflammatory bowel disease
Solution Approach 2:
The invention combines the unique properties of graphene (two-dimensional carbon structure) with nano-sizing to create a composite material that exhibits both structural stability and enhanced biological activity. This composite approach provides a new class of anti-inflammatory agents with improved versatility and effectiveness
Data Source
Figure 1A~1D
Figure 2A~2D
Figure 3A~3D
AI summary
The present invention relates to an anti-inflammatory composition comprising a graphene nano-structure as an active ingredient. Specifically, the present invention relates to a pharmaceutical composition for preventing or treating an inflammatory disease, and a cosmetic composition or feed composition for preventing or improving an inflammatory disease, which include the anti-inflammatory composition, and a method of treating an inflammatory disease, including administering the composition to a subject in need thereof.